Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,135 | 32,787 | 50,768 | 10,855 | 4,119 |
| TOTAL | $49,602 | $35,040 | $52,398 | $13,293 | $5,920 |
| Non-Current Assets | |||||
| PPE Net | 97 | 106 | 345 | 499 | 796 |
| Other Non-Current Assets | 527 | 702 | 0 | 1,731 | 439 |
| TOTAL | $624 | $808 | $345 | $2,230 | $1,235 |
| Total Assets | $50,226 | $35,848 | $52,743 | $15,523 | $7,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 9,000 | 14,716 | 8,465 | 2,094 |
| Accounts payable and accrued liabilities | 3,467 | 3,526 | 9,520 | 11,023 | 7,455 |
| Accrued Expenses | 7,361 | 8,523 | 9,714 | 21,123 | 15,046 |
| TOTAL | $10,828 | $21,049 | $33,950 | $40,611 | $24,595 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,656 | N/A | 1,526 | 10,317 | 11,957 |
| Other Non-Current Liabilities | 71,037 | 25,171 | 0 | 139,924 | 50,513 |
| TOTAL | $84,693 | $25,171 | $1,526 | $150,241 | $62,470 |
| Total Liabilities | $95,521 | $46,220 | $35,476 | $190,852 | $87,064 |
| Shareholders' Equity | |||||
| Common Shares | 214 | 191 | 131 | 21 | 21 |
| Retained earnings | -607,981 | -555,454 | -497,997 | -426,269 | -329,557 |
| TOTAL | $-45,295 | $-10,372 | $17,267 | $-175,329 | $-79,909 |
| Total Liabilities And Equity | $50,226 | $35,848 | $52,743 | $15,523 | $7,155 |